磁共振成像引导下肾活检显示高安全性和诊断率:一家三级癌症中心的经验
该研究回顾性分析了2007年11月至2020年3月间在一家三级癌症中心进行的150例连续磁共振成像引导下肾脏肿块活检,评估技术成功率和结局。结果显示组织取样诊断率为96%,无重大并发症发生,中位随访影像8年无长期并发症或肿瘤种植。作者结论认为磁共振成像引导下肾活检安全有效,应将影像引导下肾活检纳入肾脏肿块患者的管理流程,并推荐使用核心活检。
要点
- 磁共振成像引导下肾活检诊断率达96%,无重大并发症。
- 99例(66%)同时采用细针穿刺和核心活检,40例(26%)仅核心活检,3例(2%)仅细针穿刺。
- 中位随访影像8年,无活检相关长期并发症或肿瘤种植。
核心结论
- 磁共振成像引导下肾活检安全有效,诊断率高且无重大并发症。
- 作者认为影像引导下肾活检应纳入肾脏肿块患者的管理流程,并推荐核心活检。
研究设计与样本
- 回顾性综述本机构活检数据库,纳入2007年11月至2020年3月间150例连续磁共振成像引导下肾脏肿块活检。
- 使用闭孔1.5特斯拉磁共振成像设备,记录年龄、性别、体重指数、肿瘤特征、RENAL肾脏测量评分、磁共振扫描序列、活检技术、并发症、诊断率、病理结果和随访影像。
- 采用单变量逻辑回归评估不同参数与并发症发生的关联,采用McNemar检验评估细针穿刺和核心样本配对诊断率测量之间的关联。
诊断标准与关键数值
- 共150例患者150个病灶接受150次活检,中位肿瘤大小2.7厘米,中位体重指数28.3。
- 病灶为实性、部分坏死/囊性和以囊性为主者分别为137例、8例和5例。
- 95%的活检操作使用脂肪饱和稳态自由进动序列进行图像引导。
- 组织取样在144个(96%)病灶中获得诊断性结果。
- 任何活检操作后均未发生重大并发症,中位随访影像8年,无患者出现活检相关长期并发症或肿瘤种植。
临床应用与阅片要点
- 磁共振成像引导下肾活检可作为肾脏肿块取样的一种安全有效技术,诊断率高且无重大并发症。
- 作者推荐使用核心活检。
- 作者认为经皮影像引导下活检在肾脏肿块患者管理中起关键作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the technical success and outcomes of renal biopsies performed under magnetic resonance imaging (MRI) using a closed-bore, 1.5-Tesla MRI unit.
MATERIALS AND METHODS: We retrospectively reviewed our institutional biopsy database and included 150 consecutive MRI-guided biopsies for renal masses between November 2007 and March 2020. We recorded age, sex, BMI, tumor characteristics, RENAL nephrometry score, MRI scan sequence, biopsy technique, complications, diagnostic yield, pathologic outcome, and follow-up imaging. Univariate logistic regression was used to assess the association between different parameters and the development of complications. McNemar's test was used to assess the association between paired diagnostic yield measurements for fine-needle aspiration and core samples.
RESULTS: A total of 150 biopsies for 150 lesions were performed in 150 patients. The median tumor size was 2.7 cm. The median BMI was 28.3. The lesions were solid, partially necrotic/cystic, and predominantly cystic in 137, eight, and five patients, respectively. Image guidance using fat saturation steady-state free precession sequence was recorded in 95% of the biopsy procedures. Samples were obtained using both fine-needle aspiration (FNA) and cores in 99 patients (66%), cores only in 40 (26%), and FNA only in three (2%). Tissue sampling was diagnostic in 144 (96%) lesions. No major complication developed following any of the biopsy procedures. The median follow-up imaging duration was 8 years and none of the patients developed biopsy-related long-term complication or tumor seeding.
CONCLUSIONS: MRI-guided renal biopsy is safe and effective, with high diagnostic yield and no major complications.
CLINICAL RELEVANCE STATEMENT: Image-guided renal biopsy is safe and effective, and should be included in the management algorithm of patients with renal masses. Core biopsy is recommended.
KEY POINTS: • MRI-guided biopsy is a safe and effective technique for sampling of renal lesions. • MRI-guided biopsy has high diagnostic yield with no major complications. • Percutaneous image-guided biopsy plays a key role in the management of patients with renal masses.
引用
- Abdelsalam ME, Lu T, Baiomy A, et al. Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. Eur Radiol. 2024. PMID: 38400904. doi:10.1007/s00330-024-10656-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。